Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

From Y@h00 Finance Conversations

Edward 15 hours ago

Link to Dr Harris and Fauci conversation posted today..seems promising

Dr. Harris & Dr. Fauci - Aviptadil vs. Remdesivir in ACTIV-3 trials (VIP/RLF-100/Zyesami)
Dr. Harris & Dr. Fauci - Aviptadil vs. Remdesivir in ACTIV-3 trials (VIP/RLF-100/Zyesami)
www.youtube.com

Zaran 8 hours ago

The exchange between Dr. Harris and Dr. Anthony Fauci is very interesting and enlightening. I would be buying more if I hadn't already filled my coffers earlier this week. Another DSMB meeting is scheduled during this month of May and time has just about run out for "therapeutic" preparation for a Fall influx of Covid-19 patients as the weather cools and humidity increases. Whatever the attributes are which enhance it's viablilty and subsequent spread... The clock is ticking that much louder. Fauci, obviously was defensive and Dr. Harris critical for the lack of a therapeutic for the most serious and critical patients who need something to help them breath and respair their lungs! If you are on the sidelines and watching, you might consider this to be the time to buy in. Next week, God willing, I'm going to have the opportunity to buy more.

Online15 hours ago

Why did Harris and Fauci say it is a small company multiple times? How does it matter? Science matters, isn’t it?

Hans11 hours ago

FOX likes Dr. Harris. Maybe they will cover the story sooner than later...

Bigdog11 hours ago

People ask why is anyone still here. Because we are the only drug left in the trial! We are still standing! So until we get approval or I lose all the money I invested, I am not leaving. In fact because of this latest video I am adding 100,000 more tomorrow! Long and strong!!!

Kevin17 hours ago

Dr Harris claims "nobody could've predicted that this was gonna be the last drug standing for late-stage covid"...yet RLF investors predicted that 2 years ago!

(Old) James17 hours ago

The clip from Rep Harris was very informative; explains the obvious reason why enrollment in the Activ-3 trial slowed to a crawl. I wish we could KNOW the committee for data monitoring will take an early look at efficacy May 18. Fauci suggested it was more than just possible. I do not trust him, or the process, or the system. Even so, this meeting - plus the revamped, narrowed EUA request (NRX Hail Mary) represent Aviptadil's best chance in many months. Seems we could not get serious consideration for EUA until we were long past the Actual Emergency!

Hans18 hours ago

Dr. Harris is not using the Zyesami - he is calling it Aviptadil several times - like it

P 15 hours ago

I like that Harris mentioned BARDA ramping up

Serial Number 19 hours ago

https://www.c-span.org/video/?c5014716/user-clip-rep-andy-harris-md-questions-dr-fauci-activ-3

Brian A 20 hours ago

I see all of the Shorts and RT denigrators had Hooter’s post with a link to the NIH’s Senate Funding hearing removed. I will work diligently throughout the day, EVERY day, to ensure a link to this C-Span Video remains available to anyone who wants to see it.

A Link to the C-Span Video can be found in the “Replies.” Thanks to Hooter for the original informational Post.

Kevin 2 days ago

so VERU "soars" because they EXPECT to submit for EUA second half of 2022...yet we have an EUA application already submitted with peer reviewed data...and people think they are going to succeed first? Vasoactive Intestinal Peptide blocks replication of the SARSCoV-2 virus, inhibits cytokine synthesis, prevents cytopathy, and upregulates surfactant production in human pulmonary cells. Apparently it can do everything except help the FDA get their head out of the sand.